By Eric Pujade-Lauraine, Isabelle Ray-Coquard, Fabrice Lécuru
This e-book offers an summary of the newest advancements within the options and administration of ovarian melanoma. the hot info offered all through opens how one can appreciably diversified healing techniques. surgical procedure is still the center of ovarian melanoma remedy, yet its final objective and the normal surgery have developed, giving upward thrust to the query of the way to label professional facilities for debulking surgical procedure. Neo-adjuvant chemotherapy is gaining popularity and can be a brand new box for trying out novel drug combinations.
Over fresh years, ovarian melanoma administration has embraced molecular biology. it's now extra right to speak about cancers of the ovary instead of ovarian melanoma, because it isn't really a different ailment yet a number of entities with assorted molecular drivers. the numerous advances in medicines concentrating on the microenvironment or the tumor mobilephone DNA fix mechanisms are awarded intimately including intriguing destiny perspectives.
All those advances wouldn't have been attainable with no collaborative teams equivalent to the GINECO workforce in France and their integration in wider scientific learn networks on the ecu (ENGOT) and foreign (GCIG) level.
Read or Download Ovarian Cancers: Advances through International Research Cooperation (GINECO, ENGOT, GCIG) PDF
Best obstetrics & gynecology books
(Martin Dunitz) ny Univ. , big apple urban. Atlas for postgraduates interested in the surgical administration of gynecological malignancy. encompasses a complete description of the vast majority of investigative and surgeries required of the gynecological oncologist. offers transparent written and pictorial guideline.
The greatest textual content in gynecology is in its Fourteenth variation, completely revised and up to date and now in complete colour all through. equipped into 8 sections, this entire and common gynecological textbook presents information for the administration of particular gynecological stipulations. the 1st sections hide rules of perform and preliminary review and the suitable uncomplicated technology.
This publication brings jointly the main updated information regarding the body structure of progestogens. This quantity addresses the bidirectional communique among hormones, fertility, tumors, and autoimmunity. It offers the fundamental technology and medical views of progestogens that have now not been formerly on hand in a single quantity.
This e-book addresses methodological elements of epidemiological stories on maternal drug use in being pregnant. Discussing the prevailing resources of errors and the way they could produce improper conclusions, it examines a variety of epidemiological ideas and assesses their strengths and weaknesses. those refer either to the identity of results (with particular emphasis on congenital malformations) and to the categories of publicity (drug use).
Extra resources for Ovarian Cancers: Advances through International Research Cooperation (GINECO, ENGOT, GCIG)
2014;32(7):618–26. 3 Debulking Surgery: Interval Debulking Surgery Versus Primary: Pros and Cons on How to Evaluate Quality Fabrice Lécuru, Charlotte Ngo, Anne Sophie Bats, Chérazade Bensaid, Pierre Combe, Eric Pujade-Lauraine, Marie Aude le Frère Belda, and Laure Fournier Abstract Surgery for advanced ovarian cancer should now take into account the modern data on the pathophysiology of these diseases and the results of randomized trials. Initial management of chemosensitive diseases such as high-grade serous carcinoma, grade 3 endometrioïd cancer, and carcinosarcomas relies on surgery and chemotherapy.
15. van der Burg MEL, van Lent M, Buyse M, Kobierska A, Colombo N, Favalli G, Lacave A, Nardi M, Renard J, Pecorelli S. The effect of debulking surgery after induction chemotherapy on the prognosis in advanced epithelial ovarian cancer. N Engl J Med. 1995;332:629–34. 16. Rose Rose PG, Nerenstone S, Brady MF, Clarke-Pearson D, Olt G, Rubin S, Moore D, Small J. Secondary surgical cytoreduction for advanced ovarian carcinoma. N Engl J Med. 2004;351:2489–97. 17. Vergote I, Tropé C, Amant F, Kristensen G, Ehlen T, Jonhson N, Verheijen R, van der Burg M, Lacave A, Benedetti Panici PL, Kenter G, Casado A, Mendiola C, Coens C, Verleye L, Stuart 42 18.
J Clin Oncol 2015;33(17):1902–9. 34. Lynch HT, Shaw MW, Magnuson CW, et al. Hereditary factors in cancer: study of two large Midwestern kindreds. Arch Intern Med. 1966;117:206–12. 35. Piñol V, Castells A, Andreu M, Castellví-Bel S, Alenda C, Llor X, Xicola RM, RodríguezMoranta F, Payá A, Jover R, Bessa X, Gastrointestinal Oncology Group of the Spanish Gastroenterological Association. Accuracy of revised Bethesda guidelines, microsatellite instability, and immunohistochemistry for the identification of patients with hereditary nonpolyposis colorectal cancer.